HAL (France)open access
Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD
0, Causal mediation analysis, Cardiovascular outcomes, Finerenone, Mineralocorticoid receptor antagonist, Albuminuria, Albuminuria cardiovascular outcomes causal mediation analysis finerenone mineralocorticoid receptor antagonist
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1053380
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.